Title : Role of chromosomal instability and clonal heterogeneity in the therapy response of breast cancer cell lines.

Pub. Date : 2020 Nov 15

PMID : 33299647






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ERalpha+/HER2- cells with intermediate CIN were sensitive to treatment with taxanes (DOC) and anthracyclines (DOX), while ERalpha-/HER2-, ERalpha+/HER2+, and ERalpha-/HER2+ cells with intermediate CIN were resistant to these treatments. Anthracyclines erb-b2 receptor tyrosine kinase 2 Homo sapiens